A preliminary study reported that a blood test to detect early-stage pancreatic cancer achieved 98% specificity & 73% sensitivity!
The test could accurately distinguish pancreatic ductal adenocarcinoma (PDAC) from other non-cancer pancreatic conditions.
Learn more at 
https://www.science.org/doi/10.1126/scitranslmed.adq3110
Reference: Montoya Mira, et al. Sci Transl Med. 2025;17(785):eadq3110. PMID: 39937880.